Understanding how CUX1 affects blood stem cell diversity
Establishing CUX1 as a determinant of Hematopoietic Stem cell heterogeneity
This study is looking at how a protein called CUX1 affects blood stem cells, which are important for making blood, to help us understand how changes in CUX1 might influence blood health and disorders.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10903949 on NIH RePORTER |
What this research studies
This research investigates the role of a specific transcription factor, CUX1, in the diversity of hematopoietic stem cells (HSCs), which are crucial for blood formation. By using a specially designed mouse model, the study aims to uncover how varying levels of CUX1 influence the behavior and characteristics of these stem cells. The researchers will analyze the relationship between CUX1 expression and the ability of HSCs to repopulate blood cells, potentially revealing new insights into blood disorders. This work could lead to a better understanding of how stem cells make decisions that affect blood health.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with blood disorders or conditions that affect hematopoietic stem cells.
Not a fit: Patients with non-hematological conditions or those not affected by blood disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for blood-related diseases by targeting the mechanisms that govern stem cell behavior.
How similar studies have performed: Previous research has shown that understanding transcription factors can significantly impact our knowledge of stem cell behavior, indicating potential for success in this area.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Martinez, Tanner Clark — University of Chicago
- Study coordinator: Martinez, Tanner Clark
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.